Key points are not available for this paper at this time.
Insulin icodec is a novel, long-acting, once-weekly basal insulin analog. Its comparative efficacy and safety with basal once-daily insulins in type 2 diabetes mellittus is uncertain.
Ribeiro et al. (Fri,) studied this question.